# US 2025/0122541 A1 · Enzymatic and chemical catalysis for production from glucose of the pharmaceutical precursor, s-3-hydroxy- y -butyrolactone hbl

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0122541 A1
- Document ID: US20250122541A1
- Status: Published application
- Kind: A1
- Application number: 18/913,632
- Filed: 2024-10-11
- Published: 2025-04-17
- Earliest claimed: 2023-10-11
- Assignees: United States as Represented by the Secretary of Agriculture; University of Maine; Wisconsin Alumni Research Foundation
- Applicants: The United States, as represented by the Secretary of Agriculture; University of Maine; Wisconsin Alumni Research Foundation
- Inventors: Philip J. Kersten; Thomas J. Schwartz; James A. Dumesic
- Web page: https://patentgrep.com/patent/US20250122541A1

## CPC

- C12P 7/62: Carboxylic acid esters
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/88: Lyases (4.)
- C12P 17/04: containing a five-membered hetero ring, e.g. griseofulvin {, vitamin C}
- C12P 17/06: containing a six-membered hetero ring, e.g. fluorescein
- C12Y 101/0301: Pyranose oxidase (1.1.3.10)
- C12Y 402/0111: Aldos-2-ulose dehydratase (4.2.1.110)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

A method of synthesizing(S)-3-hydroxy-γ-butyrolactone (HBL), the method including producing a trione using an enzymatic conversion of glucosone. The enzymatic conversion may include: mutating a domain of Aldos-2-ulose dehydratase (AUDH) to obtain a mutant AUDH; dehydrating glucosone using the mutant AUDH to obtain an intermediate, basidiopyrone P (BPP) (4,5-dihydroxy-2-(hydroxymethyl)-2H-pyran-5-one); and forming the trione from the BPP. The method may further include catalyzing the trione using a base to form an ester of 3,4-dihydroxybutyrate; and converting the ester of 3,4-dihydroxybutyrate into the HBL by adding an acid to the ester of 3,4-dihydroxybutyrate.

## Claims

### Claim 1

A method of synthesizing(S)-3-hydroxy-γ-butyrolactone (HBL), the method comprising:
producing a trione using an enzymatic conversion of glucosone;
wherein the enzymatic conversion comprises:
mutating a domain of Aldos-2-ulose dehydratase (AUDH) to obtain a mutant AUDH;
dehydrating glucosone using the mutant AUDH to obtain an intermediate, basidiopyrone P (BPP) (4,5-dihydroxy-2-(hydroxymethyl)-2H-pyran-5-one); and
forming the trione from the BPP;
catalyzing the trione using a base to form an ester or salt of 3,4-dihydroxybutyrate; and
converting the ester or salt of 3,4-dihydroxybutyrate into the HBL by adding an acid to the ester of 3,4-dihydroxybutyrate.

### Claim 2 (depends on 1)

The method of claim 1, wherein the acid is added to the ester of 3,4-dihydroxybutyrate to reduce pH to lower than 3.

### Claim 3 (depends on 1)

The method of claim 1, wherein an amount of acid is added to decrease the pH to between about 2 and about 3.

### Claim 4 (depends on 1)

The method of claim 1, wherein the mutant AUDH has a single amino acid substitution.

### Claim 5 (depends on 4)

The method of claim 4, wherein the single amino acid substitution inhibits formation of cortalcerone.

### Claim 6 (depends on 1)

The method of claim 1, wherein the intermediate basidiopyrone P (BPP), has the formula:

### Claim 7 (depends on 1)

The method of claim 1, wherein the base is a weak base having a pKa of between 6-11.

### Claim 8 (depends on 1)

The method of claim 1, wherein a yield of HBL is greater than 80%.

### Claim 9 (depends on 1)

The method of claim 1, wherein the synthesized HBL is greater than 95% chiral(S)-HBL.

### Claim 10 (depends on 1)

The method of claim 1, wherein the oxidizing of glucose to glucosone is performed in an inflatable bag as a reactor.

### Claim 11 (depends on 1)

The method of claim 1, wherein the mutated domain of AUDH is domain 1.

### Claim 12

A method of synthesizing(S)-3-hydroxy-γ-butyrolactone (HBL), the method comprising:
producing a trione using an enzymatic conversion of glucose;
wherein the enzymatic conversion comprises:
oxidizing glucose using pyranose-2-oxidase (POX) to obtain glucosone;
mutating a domain of Aldos-2-ulose dehydratase (AUDH) to obtain a mutant AUDH;
dehydrating the glucosone using the mutant AUDH to obtain an intermediate, basidiopyrone P (BPP) (4,5-dihydroxy-2-(hydroxymethyl)-2H-pyran-5-one); and
forming the trione from the BPP;
catalyzing the trione using a base to form a mixture of an ester of 3,4-dihydroxybutyrate and glycolate; and
converting the ester of 3,4-dihydroxybutyrate and glycolate into the HBL and glycolic acid by adding an acid to the mixture.

### Claim 13 (depends on 12)

The method of claim 12, wherein the glucose has a concentration of about 20 wt % or less in a weakly buffered solution.

### Claim 14 (depends on 12)

The method of claim 12, wherein the glucose is β-D-glucose.

### Claim 15 (depends on 12)

The method of claim 12, wherein the POX is combined with an electron receptor selected from the group consisting of oxygen and quinones to obtain the glucosone.

### Claim 16 (depends on 12)

The method of claim 12, wherein the intermediate basidiopyrone P (BPP), has the formula:

### Claim 17 (depends on 12)

The method of claim 12, wherein the domain of the AUDH is mutated by a single-amino-acid substitution that prevents the isomerization of BPP to form cortalcerone.

### Claim 18 (depends on 12)

The method of claim 12, wherein a yield of synthesized HBL is greater than 80%.

### Claim 19 (depends on 12)

The method of claim 12, wherein the synthesized HBL is 95% or higher chiral(S)-HBL.

### Claim 20 (depends on 12)

The method of claim 12, wherein the oxidizing of glucose to glucosone is performed in an inflatable bag as a reactor.
